<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30120165</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1549-490X</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>The oncologist</Title>                <ISOAbbreviation>Oncologist</ISOAbbreviation>            </Journal>            <ArticleTitle>Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">theoncologist.2018-0184</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2018-0184</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although chemotherapy-induced alopecia (CIA) is considered temporary, some patients report persistent alopecia several years after chemotherapy. There is, however, a paucity of long-term prospective data on the incidence and impact of permanent CIA (PCIA). The objective of our study was to estimate the long-term incidence of PCIA in a cohort of patients with breast cancer whose hair volume and density were measured prior to chemotherapy and who were followed for 3 years after chemotherapy.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Prospective cohort study of consecutive patients ≥18 years of age with postoperative diagnosis of stage I-III breast cancer expected to receive adjuvant chemotherapy at the outpatient breast cancer clinic at the Samsung Medical Center in Seoul, Korea, from February 2012 to July 2013 (<i>n</i> = 61). Objective hair density and thickness were measured using a noninvasive bioengineering device.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The proportion of participants who had PCIA at 6 months and 3 years was 39.5% and 42.3%, respectively. PCIA was characterized in most patients by incomplete hair regrowth. Patients who received a taxane-based regimen were more likely to experience PCIA compared with patients with other types of chemotherapy. At a 3-year follow-up, hair thinning was the most common problem reported by study participants (75.0%), followed by reduced hair volume (53.9%), hair loss (34.6%), and gray hair (34.6%).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PCIA is a common adverse event of breast cancer adjuvant cytotoxic chemotherapy. Clinicians should be aware of this distressing adverse event and develop supportive care strategies to counsel patients and minimize its impact on quality of life.</AbstractText>                <AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">Knowledge of permanent chemotherapy-induced alopecia, an under-reported adverse event, should lead to optimized pretherapy counseling, anticipatory coping techniques, and potential therapeutic strategies for this sequela of treatment.</AbstractText>                <CopyrightInformation>© AlphaMed Press 2018.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kang</LastName>                    <ForeName>Danbee</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Clinical Epidemiology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Im-Ryung</ForeName>                    <Initials>IR</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Education Center, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Choi</LastName>                    <ForeName>Eun-Kyung</ForeName>                    <Initials>EK</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Education Center, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Im</LastName>                    <ForeName>Young Hyuck</ForeName>                    <Initials>YH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology/Oncology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park</LastName>                    <ForeName>Yeon Hee</ForeName>                    <Initials>YH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology/Oncology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ahn</LastName>                    <ForeName>Jin Seok</ForeName>                    <Initials>JS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology/Oncology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Jeong Eon</ForeName>                    <Initials>JE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nam</LastName>                    <ForeName>Seok Jin</ForeName>                    <Initials>SJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Hae Kwang</ForeName>                    <Initials>HK</Initials>                    <AffiliationInfo>                        <Affiliation>Amorepacific R&amp;D Center, Yongin, South Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park</LastName>                    <ForeName>Ji-Hye</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Dong-Youn</ForeName>                    <Initials>DY</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lacouture</LastName>                    <ForeName>Mario E</ForeName>                    <Initials>ME</Initials>                    <AffiliationInfo>                        <Affiliation>Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guallar</LastName>                    <ForeName>Eliseo</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Clinical Epidemiology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cho</LastName>                    <ForeName>Juhee</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea jcho@skku.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Clinical Epidemiology, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Education Center, Samsung Comprehensive Cancer Center, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Oncologist</MedlineTA>            <NlmUniqueID>9607837</NlmUniqueID>            <ISSNLinking>1083-7159</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Alopecia</Keyword>            <Keyword MajorTopicYN="N">Breast neoplasm</Keyword>            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>            <Keyword MajorTopicYN="N">Cohort</Keyword>        </KeywordList>        <CoiStatement>Disclosures of potential conflicts of interest may be found at the end of this article.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30120165</ArticleId>            <ArticleId IdType="pii">theoncologist.2018-0184</ArticleId>            <ArticleId IdType="doi">10.1634/theoncologist.2018-0184</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>